Daniel Moon

Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of Lu-177-PSMA-617 Prior to Prostatectomy

Nattakorn Dhiantravan, John Violet, Renu Eapen, Omar Alghazo, Mark Scalzo, Price Jackson, Simon P Keam, Catherine Mitchell, Paul J Neeson, Shahneen Sandhu, Scott G Williams, Daniel Moon, Nathan Lawrentschuk, Arun Azad, Michael S Hofman, Declan G Murphy

Journal article  |  2021  |  European Urology Focus

LuTectomy is an open-label phase 1/2 nonrandomised clinical trial evaluating the dosimetry, efficacy, and toxicity of the lutetium..

Study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 radionuclide therapy prior to radical prostatectomy in men with high-risk localized prostate cancer (LuTectomy study).

Omar Alghazo, Renu Eapen, Nattakorn Dhiantravan, John A Violet, Price Jackson, Mark Scalzo, Simon P Keam, Catherine Mitchell, Paul J Neeson, Shahneen Kaur Sandhu, Scott Williams, Daniel Moon, Nathan Lawrentschuk, Arun Azad, Michael S Hofman, Declan G Murphy

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

TPS264 Background: High-risk localised prostate cancer (HRCaP) is treated by radical prostatectomy (RP) or radiotherapy. Despite ..

Omission of Cortical Renorrhaphy During Robotic Partial Nephrectomy: A Vattikuti Collective Quality Initiative Database Analysis

Sohrab Arora, Chandler Bronkema, James R Porter, Alexander Mottrie, Prokar Dasgupta, Benjamin Challacombe, Koon H Rha, Rajesh K Ahlawat, Umberto Capitanio, Sudhir Rawal, Daniel A Moon, Ananthakrishnan Sivaraman, Kris K Maes, Fansesco Porpiglia, Gagan Gautam, Levent Turkeri, Mahendra Bhandari, Wooju Jeong, Mani Menon, Craig G Rogers, et al.

Journal article  |  2020  |  Urology

OBJECTIVES: To analyze the outcomes of patients in whom cortical (outer) renorrhaphy (CR) was omitted during robotic partial nephr..

Predicting intra-operative and postoperative consequential events using machine-learning techniques in patients undergoing robot-assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database study

Mahendra Bhandari, Anubhav Reddy Nallabasannagari, Madhu Reddiboina, James R Porter, Wooju Jeong, Alexandre Mottrie, Prokar Dasgupta, Ben Challacombe, Ronney Abaza, Koon Ho Rha, Dipen J Parekh, Rajesh Ahlawat, Umberto Capitanio, Thyavihally B Yuvaraja, Sudhir Rawal, Daniel A Moon, Nicolo M Buffi, Ananthakrishnan Sivaraman, Kris K Maes, Francesco Porpiglia, et al.

Journal article  |  2020  |  BJU International

OBJECTIVE: To predict intra-operative (IOEs) and postoperative events (POEs) consequential to the derailment of the ideal clinical..

The tumor immune microenvironment of germline BRCA1/2 and sporadic prostate cancer

Anna S Trigos, Anupama Pasam, Patricia Diana Banks, Roslyn Wallace, Simon P Keam, Heather Thorne, Catherine Mitchell, David Clouston, Declan G Murphy, Nathan Lawrentschuk, Damien M Bolton, Daniel Moon, Elena Castro, David Olmos, Phillip K Darcy, Ygal Haupt, Scott Williams, David L Goode, Paul J Neeson, Shahneen Kaur Sandhu

Conference Proceedings  |  2020  |  Journal of Clinical Oncology

152 Background: Prostate cancer (PC) is considered an immunologically ‘cold’ tumor and therefore patients are generally not consi..

Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial

Patrick Bowden, Andrew W See, Mark Frydenberg, Hodo Haxhimolla, Anthony J Costello, Daniel Moon, Paul Ruljancich, Jeremy Grummet, Alan Crosthwaite, Ganes Pranavan, Justin S Peters, Kevin So, Stella M Gwini, Dean P McKenzie, Skye Nolan, Lloyd ML Smyth, Craig Everitt

Journal article  |  2020  |  International Journal of Cancer

Stereotactic body radiotherapy (SBRT) can delay escalation to systemic treatment in men with oligometastatic prostate cancer (PCa)..

The ERUS Curriculum for Robot-assisted Partial Nephrectomy: Structure Definition and Pilot Clinical Validation

Alessandro Larcher, Geert De Naeyer, Filippo Turri, Paolo Dell'Oglio, Umberto Capitanio, Justin W Collins, Peter Wiklund, Henk Van Der Poel, Francesco Montorsi, Alexandre Mottrie, Ithaar Derweesh, Alessandro Volpe, Jihad Kaouk, Vincenzo Ficarra, Francesco Porpiglia, Stefan Siemer, Koon Rha, Jens Uwe Stolzenburg, Rajesh Ahlawat, Declan Murphy, et al.

Journal article  |  2019  |  European Urology

BACKGROUND: No validated training program for robot-assisted partial nephrectomy (RAPN) exists. OBJECTIVE: To define the structure..

Adverse impact of malnutrition markers on major abdominopelvic cancer surgery

Niranjan J Sathianathen, Mary Kwaan, Nathan Lawrentschuk, Christopher J Weight, Simon P Kim, Declan G Murphy, Daniel A Moon, Badrinath R Konety

Journal article  |  2019  |  ANZ Journal of Surgery

BACKGROUND: Malnutrition has been associated with adverse postoperative outcomes in a range of procedures but none have evaluated ..

Interim safety analysis of RAPPORT trial - SABR with pembrolizumab in oligometastatic RCC

S Siva, M Bressel, S Sandhu, B Tran, J Mooi, J Lewin, S Loi, G Toner, D Moon, J Goad, M Shaw, S Chander, T Eade, A Guminski, D Jayamanne, D Pryor, K Cuff, S Wood, N Lawrentschuk, D Murphy

Conference Proceedings  |  2019  |  Radiotherapy and Oncology

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A Selth, Stephen Q Wong, Laura H Porter, Natalie Lister, David Pook, Carmel J Pezaro, David L Goode, Richard J Rebello, Ashlee K Clark, Melissa Papargiris, Jenna Van Gramberg, Adrienne R Hanson, Patricia Banks, Hong Wang, Birunthi Niranjan, Shivakumar Keerthikumar, Shelley Hedwards, et al.

Journal article  |  2018  |  European Urology

BACKGROUND: The intractability of castration-resistant prostate cancer (CRPC) is exacerbated by tumour heterogeneity, including di..